Header Logo

Connection

Julie Schneider to tau Proteins

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about tau Proteins.
Julie Schneider
Connection Strength
3.148
tau Proteins
  1. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.211
  2. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.193
  3. Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance. Alzheimers Dement. 2021 07; 17(7):1244-1256.
    View in: PubMed
    Score: 0.181
  4. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.168
  5. Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains. J Cell Sci. 2019 07 15; 132(14).
    View in: PubMed
    Score: 0.163
  6. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A?, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430.
    View in: PubMed
    Score: 0.158
  7. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains. Nat Neurosci. 2019 01; 22(1):37-46.
    View in: PubMed
    Score: 0.156
  8. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.155
  9. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.152
  10. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults. PLoS One. 2016; 11(7):e0157452.
    View in: PubMed
    Score: 0.132
  11. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016 Jan; 131(1):87-102.
    View in: PubMed
    Score: 0.127
  12. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.125
  13. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 2015 May; 129(5):757-62.
    View in: PubMed
    Score: 0.120
  14. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.103
  15. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.102
  16. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.
    View in: PubMed
    Score: 0.055
  17. Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023 08 01; 146(8):3192-3205.
    View in: PubMed
    Score: 0.054
  18. When Alzheimer's is LATE: Why Does it Matter? Ann Neurol. 2023 08; 94(2):211-222.
    View in: PubMed
    Score: 0.053
  19. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.052
  20. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain. 2022 08 27; 145(8):2823-2833.
    View in: PubMed
    Score: 0.050
  21. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. J Neuropathol Exp Neurol. 2021 01 20; 80(2):102-111.
    View in: PubMed
    Score: 0.045
  22. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.045
  23. Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns. J Neuropathol Exp Neurol. 2020 11 01; 79(11):1141-1146.
    View in: PubMed
    Score: 0.044
  24. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. Neurobiol Aging. 2020 09; 93:61-68.
    View in: PubMed
    Score: 0.043
  25. Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019 09 01; 142(9):2581-2589.
    View in: PubMed
    Score: 0.041
  26. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.039
  27. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.038
  28. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018 06; 21(6):811-819.
    View in: PubMed
    Score: 0.038
  29. Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiol Aging. 2018 02; 62:243.e7-243.e14.
    View in: PubMed
    Score: 0.036
  30. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.035
  31. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
    View in: PubMed
    Score: 0.028
  32. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.027
  33. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
    View in: PubMed
    Score: 0.027
  34. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.027
  35. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.025
  36. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.025
  37. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8.
    View in: PubMed
    Score: 0.023
  38. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. J Alzheimers Dis. 2008 Feb; 13(1):53-66.
    View in: PubMed
    Score: 0.018
  39. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007 Jul; 114(1):5-22.
    View in: PubMed
    Score: 0.018
  40. The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis. 2007 Mar; 11(1):13-23.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.